Research Insight
Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide
Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of...
Techno Trends
Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
Merck KGaA announced the upcoming introduction of the new device RebiDose, the Rebif single use pre-filled pen, for the self-administration of Rebif (interferon beta-1a),...
News
First HIV diagnostic assay Results Available in Less Than 50 Minutes
Ortho Clinical Diagnostics announced U.S. FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV...
News
Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food...
Techno Trends
UCSB scientists discover inner workings of potent cancer drug
A potent drug derived from an evergreen tree may soon save the lives of some patients with the deadliest form of breast cancer. According...
Press Releases
Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach
NEW YORK, NY and Whitehouse Station, NJ (October 13, 2010) – Weight Watchers International, Inc., the world's leading provider of weight management services, and...
Drug Research
Helix BioPharma Corp. completes Definative GLP toxicology studies with L-DOS47
Helix BioPharma Corp. announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
